HealO Medical®, LLC

HealO's patented, disruptive wound care platform accelerates the healing of chronic wounds by enhancing blood flow, oxygenation and therapeutic efficacy.

Chronic wounds affect 6.5M patients in the U.S., costing $50B/yr. Average time to healing is a protracted 6-month due to inadequate blood flow and oxygenation. Our award-winning patented therapy platform will cut healing time and costs in ways previously unattainable. FDA clearance is anticipated in January 2020. Based on current CMS reimbursement and 0.16% market share (excluding acute wound care market) net profit of $13.5 million is expected.

Basics

  • Number of Employees
  • Stage
    Full Product Ready
  • Primary Industry

Description

Chronic wounds affect 6.5M patients in the U.S., costing $50B/yr. Average time to healing is a protracted 6-month due to inadequate blood flow and oxygenation. Our award-winning patented therapy platform will cut healing time and costs in ways previously unattainable. FDA clearance is anticipated in January 2020. Based on current CMS reimbursement and 0.16% market share (excluding acute wound care market) net profit of $13.5 million is expected.